Glenmark Case Study Empowering Health, Digitally | Futuready

Glenmark

Empowering Health, Digitally

15M+
Campaign Reach
200%
HCP Engagement Rate
Content Consumption Growth
12
Therapeutic Areas
Glenmark case study
Overview

Two Audiences. One Brand. Completely Different Conversations.

Pharmaceutical brands rarely get to choose a single audience. Glenmark, with operations across dermatology, respiratory, oncology and nine other therapeutic areas, had to communicate simultaneously with two groups who evaluate information completely differently. A dermatologist weighing up a new treatment option reads for clinical detail, published data and mechanism of action. A patient managing a chronic skin condition reads for comprehension, reassurance and practical guidance. The tone, depth and format that earns credibility with one actively alienates the other.

This tension needed a structural answer before any content was produced. Not a compromise between the two audiences, but a system that genuinely served each of them properly.

The Challenge

A Portfolio with No Single Reader

HCP engagement and patient facing brand building had to run side by side across Glenmark's full therapeutic portfolio. The digital presence existed, but content was inconsistent in quality, sporadic in publication and not structured around either audience's actual information needs. Search visibility was low because the content programme had no keyword architecture behind it. Pieces were being published without targeting the specific queries that either HCPs or patients were actively searching.

Demand generation campaigns had reach but limited engagement quality. The gap between someone seeing the content and someone meaningfully engaging with it was wide across every vertical.

Our Approach

How we
solved it.

01
Therapeutic Area Architecture
Rather than producing content centrally and distributing it across verticals, the programme was restructured around therapeutic area clusters. Each cluster, covering dermatology, respiratory, oncology and the remaining nine areas, was given its own content strategy with audience mapping, keyword research, format decisions and publication cadence. Dermatology content was developed with the specific concerns and search behaviour of dermatologists and their patients in mind, not adapted from a generic pharma template. The same logic applied to every other vertical. This is more demanding to set up than running a single centralised programme, but it produces better results because the content is genuinely relevant to the specific communities reading it rather than being written for a hypothetical pharma audience that doesn't actually exist.
02
HCP Engagement Campaigns
HCP facing campaigns were built around clinical utility, meaning content that helped doctors do their jobs better, understand mechanisms more clearly or stay current with treatment guidelines. Formats included educational webinar support content, clinical summary cards and condition specific reference material distributed through LinkedIn and email with targeting by medical specialty and practice type. HCP engagement doubled as a direct result, a clear signal that the content was matching what practitioners were actually looking for rather than what marketing had assumed they wanted.
03
Patient facing Content and SEO
Patient-facing content was built around the questions people type into search engines when they are first encountering a diagnosis or trying to understand a condition they have been living with for years. Keyword research mapped the high volume, low authority queries across Glenmark's therapeutic areas where the brand could rank by producing genuinely useful content that existing search results weren't adequately answering. Content consumption across the programme tripled and campaign reach across all 12 verticals reached 15 million.
A Trust Metric Disguised as an Engagement Number

The Glenmark Pharmaceuticals
outcome.

A 200% increase in HCP engagement rate is not a social media vanity metric. In pharmaceutical marketing, a practitioner who genuinely engages with educational content is meaningfully more likely to prescribe or recommend a product when it's clinically appropriate. Making Glenmark a credible and useful presence in those practitioners' professional lives was the entire point of the content programme, and the engagement numbers say it landed. Charak Pharma's Ayurvedic wellness content, Jubilant Biosys's scientific thought leadership and Sun Pharma's global website rebuild each carry a version of this same credibility test, just for different pharma audiences.

FAQ

Frequently
asked.

What services did Futuready provide for Glenmark?
For Glenmark Pharmaceuticals, Futuready delivered SEO, Content Marketing, Social Media, Demand Generation. The work was structured around the realities of the pharma sector, with each channel mapped to a defined role in the funnel.
What results did Futuready achieve for Glenmark?
The Glenmark Pharmaceuticals engagement delivered: 15M+ Campaign Reach | 200% HCP Engagement Rate | 3x Content Consumption Growth | 12 Therapeutic Areas.
How long was the Glenmark engagement?
The Glenmark Pharmaceuticals programme began with a full audit, then strategy, execution and a weekly optimisation rhythm with monthly strategic reviews to keep the work aligned to business outcomes.
Can Futuready deliver similar results for my pharma brand?
Yes. The frameworks and disciplines applied for Glenmark Pharmaceuticals are directly transferable to other pharma brands. Every engagement starts with an audit to find the highest-impact opportunities for your situation.

Your brand
could be next.

Start a Project →